Navigation Links
Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets.

ScreenReady Targets for HTS assays.

ScreenReady Targets offer the following advantages:
Homogeneous assays with high reproducibility
Ready-to-use for radioligand binding assays
Stable for three months at 4C
Microformatted assays (25 μl or higher)
Resistant towards DMSO (1% - 5%)
Integration into automated systems such as PerkinElmers PlateTrak, MiniTrak and MultiPROBE II
Supplied with the appropriate PerkinElmer radioligand

ScreenReady Targets reagents have been developed for 21 GPCRs to date demonstrating the versatility and broad applicability of this new line of HTS reagents. Please contact us at gold.service@perkinelmer.com for an updated listing of all ScreenReady Targets available.

References

Feighner et al . (1999) Science 284, 2184-2188.

Thielemans et al . (2001) Brain Res. 895, 119-128

Tonini et al . (1996) Pharmacol. Res. 33, 217-226. Watson et al . (1994) The G-protein linked receptor Facts Book, ed. Academic Press, 1-427.

Zhang et al . (1999) J. Biomol. Screening 4, 67-73.

Related Publications

ScreenReady Targets poster presentation: Boissonneault M. et al . (2001) Development of the Motilin Receptor as a ScreenReady Targets for High Throughput Screening.


'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis
2. Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins
3. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
4. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
5. Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System
6. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
7. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
8. Development of an adrenergic α2a receptor binding assay using the LEADseeker Multimodality Imaging System
9. Development of a CRF1 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
10. Purification of the Components of Human Macular Carotenoid-Binding Complex, Rev A
11. Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor
Post Your Comments: